ADALIMUMAB-AQVH

ADALIMUMAB-AQVH was reported 99 times

These side effects are most commonly reported by patients taking ADALIMUMAB-AQVH:

# Side effect Count
0 ACCIDENTAL EXPOSURE TO PRODUCT 34
1 PRODUCT DOSE OMISSION ISSUE 31
2 DEVICE MALFUNCTION 28
3 NO ADVERSE EVENT 15
4 DEVICE LEAKAGE 11
5 PRODUCT QUALITY ISSUE 9
6 PRODUCT COMPLAINT 6
7 DRUG INEFFECTIVE 5
8 DEVICE FAILURE 4
9 DEVICE ISSUE 4
10 INCORRECT DOSE ADMINISTERED 4
11 PAIN 4
12 PRODUCT LEAKAGE 4
13 DEVICE DEFECTIVE 3
14 DEVICE DIFFICULT TO USE 3
15 INJECTION SITE ERYTHEMA 3
16 INJURY ASSOCIATED WITH DEVICE 3
17 PRODUCT PACKAGING QUANTITY ISSUE 3
18 RASH 3
19 ABDOMINAL PAIN UPPER 2
20 ARTHRALGIA 2
21 CONDITION AGGRAVATED 2
22 DEVICE DEPLOYMENT ISSUE 2
23 DEVICE SAFETY FEATURE ISSUE 2
24 DEVICE USE ERROR 2
25 DIARRHOEA 2
26 DRUG DOSE OMISSION BY DEVICE 2
27 FATIGUE 2
28 HEADACHE 2
29 INJECTION SITE BRUISING 2
30 INJECTION SITE IRRITATION 2
31 INJECTION SITE URTICARIA 2
32 LIQUID PRODUCT PHYSICAL ISSUE 2
33 MYALGIA 2
34 NEEDLE ISSUE 2
35 OFF LABEL USE 2
36 PAIN IN EXTREMITY 2
37 PSORIATIC ARTHROPATHY 2
38 PYREXIA 2
39 THERAPY INTERRUPTED 2
40 ABSCESS LIMB 1
41 ACNE 1
42 ACNE FULMINANS 1
43 ADENOCARCINOMA PANCREAS 1
44 ADVERSE EVENT 1
45 ANAEMIA 1
46 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1
47 ASTHENIA 1
48 BRAIN FOG 1
49 CARDIAC FAILURE ACUTE 1
50 CHEST DISCOMFORT 1
51 CLEFT PALATE 1
52 DEATH 1
53 DEVICE DELIVERY SYSTEM ISSUE 1
54 DEVICE MECHANICAL ISSUE 1
55 DEVICE OPERATIONAL ISSUE 1
56 DIFFUSE LARGE B-CELL LYMPHOMA 1
57 DRUG DELIVERY SYSTEM MALFUNCTION 1
58 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
59 DYSARTHRIA 1
60 DYSPHAGIA 1
61 EOSINOPHILIC PNEUMONIA ACUTE 1
62 FAILURE TO SUSPEND MEDICATION 1
63 GAIT DISTURBANCE 1
64 GLOMERULONEPHRITIS MINIMAL LESION 1
65 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 1
66 HAEMATOCHEZIA 1
67 HAEMORRHAGE 1
68 HEART RATE IRREGULAR 1
69 HOT FLUSH 1
70 HYPERAMMONAEMIA 1
71 HYPERSENSITIVITY 1
72 HYPOKALAEMIA 1
73 ILLNESS 1
74 INCORRECT DOSE ADMINISTERED BY DEVICE 1
75 INJECTION SITE DISCHARGE 1
76 INJECTION SITE HAEMORRHAGE 1
77 INJECTION SITE PAIN 1
78 INJECTION SITE PAPULE 1
79 INJECTION SITE PRURITUS 1
80 INJECTION SITE REACTION 1
81 INTENTIONAL DOSE OMISSION 1
82 LANGERHANS^ CELL HISTIOCYTOSIS 1
83 MALAISE 1
84 MALIGNANT ASCITES 1
85 MENTAL DISORDER 1
86 MOBILITY DECREASED 1
87 MUSCLE SPASMS 1
88 MUSCULAR WEAKNESS 1
89 MUSCULOSKELETAL DISCOMFORT 1
90 MUSCULOSKELETAL STIFFNESS 1
91 NAUSEA 1
92 PARAESTHESIA 1
93 POLYCHONDRITIS 1
94 POLYDIPSIA 1
95 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
96 PRODUCT ADMINISTRATION ERROR 1
97 PRODUCT STORAGE ERROR 1
98 PRODUCT TEMPERATURE EXCURSION ISSUE 1
99 PRODUCT USE IN UNAPPROVED INDICATION 1
100 PRODUCT USE ISSUE 1
101 PRURITUS 1
102 PYODERMA GANGRENOSUM 1
103 RASH MACULAR 1
104 RASH PRURITIC 1
105 RETINAL VASCULAR DISORDER 1
106 SITTING DISABILITY 1
107 SKIN DISCOLOURATION 1
108 SKIN REACTION 1
109 SUBACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY 1
110 SUICIDE ATTEMPT 1
111 SYRINGE ISSUE 1
112 SYSTEMIC LUPUS ERYTHEMATOSUS 1
113 TUBULOINTERSTITIAL NEPHRITIS 1
114 UNEVALUABLE EVENT 1
115 WEIGHT DECREASED 1